Universitätsklinik Freiburg
Welcome,         Profile    Billing    Logout  
 4 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Waller, Cornelius
FIND, NCT03827850 / 2018-000399-13: FGFR Inhibitor in FGFR Dysregulated Cancer

Terminated
2
22
Europe
ERDAFITINIB, JNJ -42756493, WHO NUMBER 10147
Lung Cancer Group Cologne
Lung Cancer, NSCLC, Pulmonary Neoplasm, Squamous Cell Lung Cancer, NSCLC Stage IV
09/22
10/22
NICITA, NCT04177953 / 2019-002466-13: Nivolumab with Chemotherapy in Pleural Mesothelioma After Surgery

Completed
2
92
Europe
Carboplatin AUC 5, Cisplatin 75 mg/m2, Pemetrexed 500 mg/m2, Nivolumab Injection, Opdivo
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Bristol-Myers Squibb, Thoraxklinik Heidelberg gGmbH - Universitätsklinikum Heidelberg
Pleural Mesothelioma Malignant
01/25
01/25
NCT04318938: Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping

Active, not recruiting
2
118
Europe
Brigatinib, Study treatment, Tyrosine kinase inhibitor
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Thoraxklinik-Heidelberg gGmbH, Takeda
NSCLC
01/26
01/26
NCT03125707: German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)

Recruiting
N/A
2172
Europe
Registry study
University of Ulm
BCR-ABL1-Negative Myeloid Neoplasms
09/45
09/45
Rautenberg, Beate
COMPASS, NCT03164980: Comparison of QoL Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Completed
4
89
Europe
Trabectidin (Yondelis)
North Eastern German Society of Gynaecological Oncology, Frankfurter Institut für Klinische Krebsforschung IKF GmbH, PharmaMar
Quality of Life, Ovarian Cancer, Recurrent Ovarian Carcinoma
08/23
08/23
SASCIA, NCT04595565 / 2019-004100-35: Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

Active, not recruiting
3
1332
Europe
Capecitabine, Xeloda, Carboplatin, Paraplatin, Cisplatin, Platinol, Sacituzumab govitecan, Trodelvy
German Breast Group, Gilead Sciences, Austrian Breast & Colorectal Cancer Study Group, Spanish Breast Cancer Research Group (GEICAM), ETOP IBCSG Partners Foundation, Cancer Trials Ireland, UNICANCER
HER2-negative Breast Cancer, Triple Negative Breast Cancer
03/27
03/29
ADAPTcycle, NCT04055493: Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

Active, not recruiting
3
1684
Europe
Ribociclib 200Mg Oral Tablet, Kisqali
West German Study Group, Novartis, Genomic Health®, Inc.
Breast Cancer Female
07/27
07/27
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Recruiting
3
6000
Europe, Canada, Japan, US, RoW
Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane
Eli Lilly and Company
Breast Neoplasms
10/27
03/32
Voll, Reinhard
NCT04464434 / 2019-004718-32: Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Recruiting
4
50
Europe
Upfront autologous HSCT
UMC Utrecht, ZonMw: The Netherlands Organisation for Health Research and Development, Boehringer Ingelheim, Miltenyi Biotec, Inc.
Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma, Scleroderma, Diffuse, Autologous Stem Cell Transplantation, Cyclophosphamide, Mycophenolate Mofetil, Treatment Strategy
10/27
10/30
ISLE, NCT04276701: Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases

Recruiting
N/A
500
Europe
blood sample, Ultrasonography assessment, questionnaires
University Hospital, Bordeaux, Foundation for Research in Rheumatology (FOREUM)
Systemic Lupus Erythematosus
03/27
03/27
Hasselblatt, Peter
FRESCO, NCT03843385: Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis

Recruiting
3
174
Europe
encapsulated faecal microbiota filtrate, FMFT, encapsulated faecal microbiota, FMT, Placebo, Encapsulated sterile saline
Andreas Stallmach, German Federal Ministry of Education and Research
Ulcerative Colitis, Inflammatory Bowel Diseases
01/25
07/26
ABX464-106, NCT05507216: ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

Recruiting
3
612
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
03/25
04/25
ABTECT, NCT05535946: - Maintenance

Recruiting
3
1050
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
01/26
01/30
Konstantinidis, Lukas
COLRAS, NCT05509972: In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis

Terminated
N/A
7
Europe
total knee prosthesis implantation, Columbus® Total Knee Arthroplasty
Aesculap AG, Raylytic GmbH
Knee Arthritis, Knee Osteoarthritis, Primary Osteoarthritis of Knee Nos, Secondary Osteoarthritis of Knee Nos, Rheumatoid Arthritis of Knee, Instability, Joint, Osteonecrosis, Deformity Knee
02/24
08/24

Download Options